Weekly Update #146, Lo-Fidelity (How Fidelity missed the mark on Stemcentrx)

EquityZen

May 4th, 2016

View more newsletters

Join 280,000+ global shareholders and investors on EquityZen

Marketplace

Shareholders
Investors
Managed Funds
Investment Returns

Resources

FAQs
Blog
Newsletter
IPO Center
Knowledge Center

Company

About
Careers
Press
Contact Us

Connect

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2022 EquityZen Inc. All rights reserved.

Disclosures
Business Continuity Plan
Privacy Policy
Allocation Policy
Form CRS

EquityZen Inc.
30 Broad Street,
Suite 1200
New York, NY 10004